Dosage Forms

Reshaping Dosage Forms

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Frontrunners in Bispecific Antibodies

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

GeoVax and Vaxeal to Collaborate on Cancer Immunotherapy Program

January 04, 2018

The companies will collaborate on the development of vaccines to expand GeoVax’s cancer immunotherapy program.

FDA Releases ANDA Submission Guidance

January 03, 2018

The agency published draft guidance on good practices for submitting abbreviated new drug applications.

Elucidating Parenteral Packaging Requirements for Future Drugs

January 02, 2018

The development of new packaging solutions that are fit for drugs of the future requires close collaboration between the pharmaceutical manufacturer and its packaging suppliers and machine vendors.

In-Line Force Analysis During Vial Filling

January 02, 2018

Measurements by a drone-based online pressure monitoring system help identify weak points in the filling line, enabling the process to be optimized.

Glass or Plastic—A Question of Use

January 02, 2018

Glass and plastic are well established primary packaging materials for the pharmaceutical industry but they both have their advantages and disadvantages.

Determination of Dermal PDE for Pharmaceutical Products

January 02, 2018

The authors offer recommendations for permissible daily exposures and concentration limits of elemental impurities for dermal drug products.

Auromedics Pharma Recalls Linezolid Injection Due to Mold Contamination

December 28, 2017

The recall was initiated due to a product complaint in which white particulate matter, identified as mold, was discovered in a flexible bag from one batch.

Federal Circuit Decides in Favor of Novartis in Biosimilars Patent Dispute with Amgen

December 18, 2017

The US Court of Appeals for the Federal Circuit has decided in favor of Novartis’ Sandoz in rendering the opinion that Amgen cannot use state laws to prohibit or delay the marketing of biosimilars.

FDA Approves Pfizer Biosimilar to J&J’s Remicade

December 14, 2017

FDA has approved a Pfizer biosimilar to J&J’s top-selling anti-inflammatory biologic, Remicade.

New Immunotherapy for Pediatric Brain Cancer Targets Mutated Protein

December 14, 2017

Children with a rare brainstem-based cancer might be helped by a new immunotherapy that targets a mutated protein found exclusively in cancer cells.